
A Joint Venture of Quintiles and Thermo Fisher Scientific
UPCOMING EVENTS
Clinical Trial Supply EuropeFebruary 21-22, 2012
London, United Kingdom
Clinical Trial Supply Europe
February 1-3, 2012
Basel, Switzerland
6th Forecasting and Optimizing the Clinical Supply Chain
March 19-21, 2012
Philadelphia, PA
See all events

Cenduit Continues Expansion with Key Management Hires
Andrew Roth and Kirsten Ferrandiz join Cenduit’s Management Team
November 28th, 2011 - Research Triangle Park, NC – Cenduit, LLC, a global provider of Interactive Response Technologies (IRT) for clinical trials, today announced the appointment of Andrew Roth as Global Head of Technology and Kirsten Ferrandiz as Senior Director of Account Management. Andrew and Kirsten will report directly to the VP of Customer and Project Management and will help maintain high levels of customer service and support as Cenduit continues to grow.
“As a specialist in randomization and clinical trial supply management, Cenduit is in a strong position to lead the way as clinical trials become more global and complex,” said Roth. “I will support the technology team in their ongoing efforts to maintain Cenduit’s leadership position by leveraging new technologies and working to provide the best possible user experience.”
Coupled with Roth’s expertise in technology development, Ferrandiz will forge partnerships with Cenduit’s customers while also being involved in the oversight of projects from business development through support.
“I’m excited to contribute to Cenduit’s success in the increasingly dynamic IRT space,” said Ferrandiz. “I look forward to helping Cenduit exceed the IRT demands of its clients through sophisticated technologies and excellent customer service and support.
Dr. Jogin Desai, Cenduit’s Chief Executive Officer, comments on the appointment of Roth and Ferrandiz: “Andy brings deep experience in technology both in implementation and process. His expertise will be integral to the organization as Cenduit rolls out innovative new products and continues to expand its business. Kirsten joins us with significant experience in the Interactive Response Technology (IRT) space as well as a broad product development background. She is a talented addition to our management team and will be working not only to improve Cenduit’s service offering but also to further develop key customer relationships.”
Roth is a seasoned management and technical professional with extensive experience in software systems development and design from battlefield communications and telecommunications to information technology. Roth has held leadership positions in R&D across a variety of industries and has most recently served as Director of Engineering Services at Tekelec where he was responsible for engineering infrastructure for a globally distributed R&D organization.
Ferrandiz joins Cenduit with nearly 20 years experience in the life sciences industry including extensive management background in process improvement, software systems development and design within the Interactive Response Technologies (IRT) arena. Ferrandiz has held leadership positions in both service operations and product development and most recently served as Senior Director, Product Management/Strategy at Oracle where she collaborated on IRT product roadmaps and managed key product releases.
About Cenduit, LLC
Cenduit is a leading global provider of Interactive Response Technologies (IRT) and a privately owned joint venture of Quintiles and Fisher Clinical Services, part of Thermo Fisher Scientific. Cenduit has a global staff of over 200 quality and customer service-driven IRT experts dedicated to optimizing patient randomization and drug supply management. For more information, please visit www.cenduit.com.
For media inquiries, please contact Rebecca Galloway on +1 919.998.3372 or e-mail .(JavaScript must be enabled to view this email address).
